Electrocardiographic Alterations Related to Intralesional Glucantime® Treatments: A Potentially Severe Adverse Event

array:24 ["pii" => "S0001731022005397" "issn" => "00017310" "doi" => "10.1016/j.ad.2022.06.011" "estado" => "S300" "fechaPublicacion" => "2022-07-01" "aid" => "3095" "copyrightAnyo" => "2022" "documento" => "simple-article" "crossmark" => 1 "licencia" => "http://creativecommons.org/licenses/by-nc-nd/4.0/" "subdocumento" => "crp" "cita" => "Actas Dermosifiliogr. 2022;113:T742-T744" "abierto" => array:3 [ "ES" => true "ES2" => true "LATM" => true ] "gratuito" => true "lecturas" => array:1 [ "total" => 0 ] "itemSiguiente" => array:19 [ "pii" => "S0001731022001612" "issn" => "00017310" "doi" => "10.1016/j.ad.2022.01.031" "estado" => "S300" "fechaPublicacion" => "2022-07-01" "aid" => "2950" "copyright" => "AEDV" "documento" => "simple-article" "crossmark" => 1 "licencia" => "http://creativecommons.org/licenses/by-nc-nd/4.0/" "subdocumento" => "crp" "cita" => "Actas Dermosifiliogr. 2022;113:745-7" "abierto" => array:3 [ "ES" => true "ES2" => true "LATM" => true ] "gratuito" => true "lecturas" => array:1 [ "total" => 0 ] "es" => array:11 [ "idiomaDefecto" => true "cabecera" => "CARTA CIENTÍFICO-CLÍNICA" "titulo" => "Seguimiento de pacientes con psoriasis en contexto de políticas de aislamiento domiciliario por COVID-19: Encuesta realizada a pacientes en hospital de Argentina" "tienePdf" => "es" "tieneTextoCompleto" => "es" "paginas" => array:1 [ 0 => array:2 [ "paginaInicial" => "745" "paginaFinal" => "747" ] ] "titulosAlternativos" => array:1 [ "en" => array:1 [ "titulo" => "Psoriasis While Home Isolation Policies to Contain COVID-19 Were in Effect: A Follow-up Survey of Patients Treated at an Argentine Hospital" ] ] "contieneTextoCompleto" => array:1 [ "es" => true ] "contienePdf" => array:1 [ "es" => true ] "resumenGrafico" => array:2 [ "original" => 0 "multimedia" => array:7 [ "identificador" => "fig0010" "etiqueta" => "Figura 2" "tipo" => "MULTIMEDIAFIGURA" "mostrarFloat" => true "mostrarDisplay" => false "figura" => array:1 [ 0 => array:4 [ "imagen" => "gr2.jpeg" "Alto" => 768 "Ancho" => 2091 "Tamanyo" => 114426 ] ] "descripcion" => array:1 [ "es" => "Causas de suspensión de tratamiento durante el ASPO." ] ] ] "autores" => array:1 [ 0 => array:2 [ "autoresLista" => "Germán Gastón Mangiarotti, Cintia Marisol Arias, Elizabeth Zak, Gimena Antonia Castro Pérez" "autores" => array:4 [ 0 => array:2 [ "nombre" => "Germán Gastón" "apellidos" => "Mangiarotti" ] 1 => array:2 [ "nombre" => "Cintia Marisol" "apellidos" => "Arias" ] 2 => array:2 [ "nombre" => "Elizabeth" "apellidos" => "Zak" ] 3 => array:2 [ "nombre" => "Gimena Antonia" "apellidos" => "Castro Pérez" ] ] ] ] ] "idiomaDefecto" => "es" "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S0001731022001612?idApp=UINPBA000044" "url" => "/00017310/0000011300000007/v1_202207140532/S0001731022001612/v1_202207140532/es/main.assets" ] "itemAnterior" => array:18 [ "pii" => "S0001731022002551" "issn" => "00017310" "doi" => "10.1016/j.ad.2021.04.012" "estado" => "S300" "fechaPublicacion" => "2022-07-01" "aid" => "2986" "documento" => "simple-article" "crossmark" => 1 "licencia" => "http://creativecommons.org/licenses/by-nc-nd/4.0/" "subdocumento" => "crp" "cita" => "Actas Dermosifiliogr. 2022;113:742-4" "abierto" => array:3 [ "ES" => true "ES2" => true "LATM" => true ] "gratuito" => true "lecturas" => array:1 [ "total" => 0 ] "es" => array:11 [ "idiomaDefecto" => true "cabecera" => "CARTA CIENTÍFICO-CLÍNICA" "titulo" => "Alteraciones electrocardiográficas por Glucantime® intralesional, un evento adverso potencialmente grave" "tienePdf" => "es" "tieneTextoCompleto" => "es" "paginas" => array:1 [ 0 => array:2 [ "paginaInicial" => "742" "paginaFinal" => "744" ] ] "titulosAlternativos" => array:1 [ "en" => array:1 [ "titulo" => "Electrocardiographic Alterations Related to Intralesional Glucantime® Treatments: A Potentially Severe Adverse Event" ] ] "contieneTextoCompleto" => array:1 [ "es" => true ] "contienePdf" => array:1 [ "es" => true ] "resumenGrafico" => array:2 [ "original" => 0 "multimedia" => array:7 [ "identificador" => "fig0005" "etiqueta" => "Figura 1" "tipo" => "MULTIMEDIAFIGURA" "mostrarFloat" => true "mostrarDisplay" => false "figura" => array:1 [ 0 => array:4 [ "imagen" => "gr1.jpeg" "Alto" => 468 "Ancho" => 900 "Tamanyo" => 66814 ] ] "descripcion" => array:1 [ "es" => "Placa de 3,5 cm, eritematoedematosa e infiltrada localizada en la frente, que correspondía a una lesión por Leishmania." ] ] ] "autores" => array:1 [ 0 => array:2 [ "autoresLista" => "B. García Bracamonte, S. Burillo Martínez, C. Morales Raya, P. Ortiz Romero" "autores" => array:4 [ 0 => array:2 [ "nombre" => "B." "apellidos" => "García Bracamonte" ] 1 => array:2 [ "nombre" => "S." "apellidos" => "Burillo Martínez" ] 2 => array:2 [ "nombre" => "C." "apellidos" => "Morales Raya" ] 3 => array:2 [ "nombre" => "P." "apellidos" => "Ortiz Romero" ] ] ] ] ] "idiomaDefecto" => "es" "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S0001731022002551?idApp=UINPBA000044" "url" => "/00017310/0000011300000007/v1_202207140532/S0001731022002551/v1_202207140532/es/main.assets" ] "asociados" => array:1 [ 0 => array:18 [ "pii" => "S0001731022002551" "issn" => "00017310" "doi" => "10.1016/j.ad.2021.04.012" "estado" => "S300" "fechaPublicacion" => "2022-07-01" "aid" => "2986" "documento" => "simple-article" "crossmark" => 1 "licencia" => "http://creativecommons.org/licenses/by-nc-nd/4.0/" "subdocumento" => "crp" "cita" => "Actas Dermosifiliogr. 2022;113:742-4" "abierto" => array:3 [ "ES" => true "ES2" => true "LATM" => true ] "gratuito" => true "lecturas" => array:1 [ "total" => 0 ] "es" => array:11 [ "idiomaDefecto" => true "cabecera" => "CARTA CIENTÍFICO-CLÍNICA" "titulo" => "Alteraciones electrocardiográficas por Glucantime® intralesional, un evento adverso potencialmente grave" "tienePdf" => "es" "tieneTextoCompleto" => "es" "paginas" => array:1 [ 0 => array:2 [ "paginaInicial" => "742" "paginaFinal" => "744" ] ] "titulosAlternativos" => array:1 [ "en" => array:1 [ "titulo" => "Electrocardiographic Alterations Related to Intralesional Glucantime® Treatments: A Potentially Severe Adverse Event" ] ] "contieneTextoCompleto" => array:1 [ "es" => true ] "contienePdf" => array:1 [ "es" => true ] "resumenGrafico" => array:2 [ "original" => 0 "multimedia" => array:7 [ "identificador" => "fig0005" "etiqueta" => "Figura 1" "tipo" => "MULTIMEDIAFIGURA" "mostrarFloat" => true "mostrarDisplay" => false "figura" => array:1 [ 0 => array:4 [ "imagen" => "gr1.jpeg" "Alto" => 468 "Ancho" => 900 "Tamanyo" => 66814 ] ] "descripcion" => array:1 [ "es" => "Placa de 3,5 cm, eritematoedematosa e infiltrada localizada en la frente, que correspondía a una lesión por Leishmania." ] ] ] "autores" => array:1 [ 0 => array:2 [ "autoresLista" => "B. García Bracamonte, S. Burillo Martínez, C. Morales Raya, P. Ortiz Romero" "autores" => array:4 [ 0 => array:2 [ "nombre" => "B." "apellidos" => "García Bracamonte" ] 1 => array:2 [ "nombre" => "S." "apellidos" => "Burillo Martínez" ] 2 => array:2 [ "nombre" => "C." "apellidos" => "Morales Raya" ] 3 => array:2 [ "nombre" => "P." "apellidos" => "Ortiz Romero" ] ] ] ] ] "idiomaDefecto" => "es" "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S0001731022002551?idApp=UINPBA000044" "url" => "/00017310/0000011300000007/v1_202207140532/S0001731022002551/v1_202207140532/es/main.assets" ] ] "en" => array:15 [ "idiomaDefecto" => true "cabecera" => "Case and Research Letter" "titulo" => " Electrocardiographic Alterations Related to Intralesional Glucantime® Treatments: A Potentially Severe Adverse Event" "tieneTextoCompleto" => true "saludo" => "To the Editor," "paginas" => array:1 [ 0 => array:2 [ "paginaInicial" => "T742" "paginaFinal" => "T744" ] ] "autores" => array:1 [ 0 => array:4 [ "autoresLista" => "B. García Bracamonte, S. Burillo Martínez, C. Morales Raya, P. Ortiz Romero" "autores" => array:4 [ 0 => array:4 [ "nombre" => "B." "apellidos" => "García Bracamonte" "email" => array:1 [ 0 => "beagarcia50@hotmail.com" ] "referencia" => array:1 [ 0 => array:2 [ "etiqueta" => "*" "identificador" => "cor0005" ] ] ] 1 => array:2 [ "nombre" => "S." "apellidos" => "Burillo Martínez" ] 2 => array:2 [ "nombre" => "C." "apellidos" => "Morales Raya" ] 3 => array:2 [ "nombre" => "P." "apellidos" => "Ortiz Romero" ] ] "afiliaciones" => array:1 [ 0 => array:2 [ "entidad" => "Hospital Universitario 12 de Octubre, Madrid, Spain" "identificador" => "aff0005" ] ] "correspondencia" => array:1 [ 0 => array:3 [ "identificador" => "cor0005" "etiqueta" => "⁎" "correspondencia" => "Corresponding author." ] ] ] ] "titulosAlternativos" => array:1 [ "es" => array:1 [ "titulo" => "Alteraciones electrocardiográficas por Glucantime® intralesional, un evento adverso potencialmente grave" ] ] "resumenGrafico" => array:2 [ "original" => 0 "multimedia" => array:7 [ "identificador" => "fig0010" "etiqueta" => "Figure 2" "tipo" => "MULTIMEDIAFIGURA" "mostrarFloat" => true "mostrarDisplay" => false "figura" => array:1 [ 0 => array:4 [ "imagen" => "gr2.jpeg" "Alto" => 1044 "Ancho" => 1550 "Tamanyo" => 439035 ] ] "descripcion" => array:1 [ "en" => "Electrocardiogram (ECG) showing a prolonged QT interval (QTc, 510ms), nonsignificant ST segment depression, and increased P wave axis." ] ] ] "textoCompleto" => "Meglumine antimoniate (MA) (Glucantime®, Sanofi-Aventis, S.A., Spain) is the treatment of choice in cutaneous leishmaniasis (CL).<a class="elsevierStyleCrossRefs" href="#bib0055">1–4</a> It is administered intramuscularly (IM) and intralesionally (IL), and is considered to be a safe and effective drug. IL administration is used in single lesions smaller than 3–4cm and IM administration is reserved for multiple lesions, complicated lesions, or cases with signs of lymphatic dissemination.<a class="elsevierStyleCrossRefs" href="#bib0055">1,3,4</a> The recommended IM dosage is between 10 and 20mg/kg/d of antimony (75mg/kg/d of MA) in 10-day cycles.<a class="elsevierStyleCrossRefs" href="#bib0065">3,5–7</a> For IL administration, much lower doses of between 0.2 and 1mL/lesion are used, in variable dosage regimens, every 0.5-1-2 weeks.<a class="elsevierStyleCrossRefs" href="#bib0055">1,3,8</a> It is well known that systemic use of the drug may cause electrocardiographic abnormalities.<a class="elsevierStyleCrossRef" href="#bib0065">3</a>An 82-year-old woman visited our department with an erythematous–edematous infiltrated lesion measuring 3.5cm, with no ulceration or scab, located on the forehead; the lesion was persistent and had appeared some months earlier (<a class="elsevierStyleCrossRef" href="#fig0005">Fig. 1</a>). The patient had a past history of rheumatoid arthritis treated with etanercept and prednisone, osteoporosis, scoliosis, mild anemia, seborrheic dermatitis treated with topical corticosteroids, and severe underweight (BMI, 15kg/m2). A skin biopsy of the lesion revealed granulomatous dermatitis with amastigotes and a diagnosis of leishmaniasis was therefore established. The patient had not traveled outside Spain. It was decided to treat the patient with oral itraconazole for 6 weeks, with good clinical and analytical tolerance but without improvement. A week later, intralesional MA was administered at a dose of 0.6–1mL on days 0, 7, and 21, following administration of lidocaine/prilocaine. The topical corticosteroids and etanercept were withdrawn from the moment of diagnosis. An electrocardiogram (ECG) performed after the 3rd dose detected a prolonged QT interval (QTc, 510ms), nonsignificant ST segment depression, and increased P wave axis (<a class="elsevierStyleCrossRef" href="#fig0010">Fig. 2</a>), and treatment was therefore suspended. The patient reported no episodes of syncope. A follow-up ECG, performed by the cardiology department 3 weeks later, was within the normal range. The cutaneous signs and symptoms resolved with the 3 doses that had already been administered.<elsevierMultimedia ident="fig0005"></elsevierMultimedia><elsevierMultimedia ident="fig0010"></elsevierMultimedia>Multiple adverse effects of systemic MA have been reported, including myalgia, arthralgia, gastrointestinal disorders (nausea, abdominal pain), headache, elevated hepatic and pancreatic enzymes, leukopenia, abnormal ECG, and severe arhythmia.<a class="elsevierStyleCrossRefs" href="#bib0065">3,5</a> Because it involves lower and more widely spaced doses, intralesional use of MA produces mild and generally local adverse effects (pain, edema, pruritus, and transitory erythema at the injection site).<a class="elsevierStyleCrossRefs" href="#bib0060">2,4,5,7–10</a> Systemic adverse effects associated with this route of administration have also been described, such as nausea, vomiting, dyspnea, dizziness, rash, myalgia, arthralgia, headache, and even anaphylactic shock.<a class="elsevierStyleCrossRef" href="#bib0100">10</a> Cardiotoxicity due to systemic antimonials is a well-known adverse effect that, according to the product information sheet, may present when used at high daily doses over long periods of time. It may produce a prolonged QT interval in the ECG, with potential development of severe arrhythmia, which may result in death. Changes in the ECG are generally dose-dependent and are usually reversible. In most cases, abnormalities such as T wave inversion and prolonged QT interval precede onset and are a warning sign of potential severe arrhythmia. A baseline ECG should be performed with a follow-up ECG every 7–10 days, and treatment should be suspended if the QTc interval exceeds 450ms.<a class="elsevierStyleCrossRefs" href="#bib0075">5,6,9</a> Ribeiro et al. also demonstrated changes in the ECG (prolonged QT) with systemic IM therapy at low doses (10mg/kg) and in short treatment durations (10 days) with potential severe implications, which make monitoring these patients using ECG recommendable.<a class="elsevierStyleCrossRef" href="#bib0080">6</a> With regard to intralesional therapy, a recent clinical study in Brazil in 53 patients who underwent a weekly ECG found a prolonged QT interval with no clinical repercussions in 25% of cases.<a class="elsevierStyleCrossRef" href="#bib0100">10</a> This effect was found to be associated with smoking.<a class="elsevierStyleCrossRef" href="#bib0100">10</a> It is, however, a poorly documented adverse effect, as ECGs are not usually performed in the clinical follow-up of intralesional therapy. In that study, the weekly doses used were much higher than those in our study. The fact that we detected this abnormality in a patient with no cardiologic risk criteria in treatment with low-dose intralesional MA leads us to believe that it is also useful to monitor the ECG in these patients.In conclusion, before instating therapy with antimonials in any form, the patient should be questioned regarding personal history of cardiac disease (heart attack, bradycardia, palpitations, syncope, etc.) and a family history of sudden death. Factors that may favor prolonged QT, such as electrolyte imbalance, should be monitored and corrected and association with other drugs that may also cause prolonged QT (<a href="http://www.qtdrugs.org/">www.qtdrugs.org</a>) (antiarrhythmics, tricyclic antidepressants, erythromycin, tetracyclines, trimethoprim/sulfamethoxazole, antipsychotics, etc.) should be avoided.<a class="elsevierStyleCrossRef" href="#bib0080">6</a> We recommend monitoring high-risk patients and watching for the appearance of a prolonged QT interval.Conflicts of InterestThe authors declare that they have no conflicts of interest." "textoCompletoSecciones" => array:1 [ "secciones" => array:2 [ 0 => array:2 [ "identificador" => "sec0005" "titulo" => "Conflicts of Interest" ] 1 => array:1 [ "titulo" => "References" ] ] ] "pdfFichero" => "main.pdf" "tienePdf" => true "multimedia" => array:2 [ 0 => array:7 [ "identificador" => "fig0005" "etiqueta" => "Figure 1" "tipo" => "MULTIMEDIAFIGURA" "mostrarFloat" => true "mostrarDisplay" => false "figura" => array:1 [ 0 => array:4 [ "imagen" => "gr1.jpeg" "Alto" => 469 "Ancho" => 901 "Tamanyo" => 67105 ] ] "descripcion" => array:1 [ "en" => "Erythematous–edematous infiltrated plaque measuring 3.5cm, located on the forehead, corresponding to a lesion due to Leishmania." ] ] 1 => array:7 [ "identificador" => "fig0010" "etiqueta" => "Figure 2" "tipo" => "MULTIMEDIAFIGURA" "mostrarFloat" => true "mostrarDisplay" => false "figura" => array:1 [ 0 => array:4 [ "imagen" => "gr2.jpeg" "Alto" => 1044 "Ancho" => 1550 "Tamanyo" => 439035 ] ] "descripcion" => array:1 [ "en" => "Electrocardiogram (ECG) showing a prolonged QT interval (QTc, 510ms), nonsignificant ST segment depression, and increased P wave axis." ] ] ] "bibliografia" => array:2 [ "titulo" => "References" "seccion" => array:1 [ 0 => array:2 [ "identificador" => "bibs0015" "bibliografiaReferencia" => array:10 [ 0 => array:3 [ "identificador" => "bib0055" "etiqueta" => "1" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Outbreak of cutaneous leishmaniasis in Fuenlabrada, Madrid" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:6 [ 0 => "M. Aguado" 1 => "P. Espinosa" 2 => "A. Romero-Maté" 3 => "J.C. Tardío" 4 => "S. Córdoba" 5 => "J. Borbujo" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1016/j.adengl.2013.03.005" "Revista" => array:6 [ "tituloSerie" => "Actas Dermosifiliogr" "fecha" => "2013" "volumen" => "104" "paginaInicial" => "334" "paginaFinal" => "342" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/23567452" "web" => "Medline" ] ] ] ] ] ] ] ] 1 => array:3 [ "identificador" => "bib0060" "etiqueta" => "2" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Efficacy of pentavalent antimoniate intralesional infiltration therapy for cutaneous leishmaniasis: a systematic review" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:3 [ 0 => "N.C. Brito" 1 => "A. Rabello" 2 => "G.F. Cota" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1371/journal.pone.0184777" "Revista" => array:6 [ "tituloSerie" => "PLOS ONE" "fecha" => "2017" "volumen" => "12" "paginaInicial" => "e0184777" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/28926630" "web" => "Medline" ] ] "itemHostRev" => array:3 [ "pii" => "S1550728914004055" "estado" => "S300" "issn" => "15507289" ] ] ] ] ] ] ] 2 => array:3 [ "identificador" => "bib0065" "etiqueta" => "3" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Leishmaniasis cutánea" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:1 [ 0 => "D. García-Almagro" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1016/s0001-7310(05)73027-1" "Revista" => array:6 [ "tituloSerie" => "Actas Dermosifiliogr" "fecha" => "2005" "volumen" => "96" "paginaInicial" => "1" "paginaFinal" => "24" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/16476327" "web" => "Medline" ] ] ] ] ] ] ] ] 3 => array:3 [ "identificador" => "bib0070" "etiqueta" => "4" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Cutaneous leishmaniasis: 20 years’ experience in a Spanish tertiary care hospital" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:5 [ 0 => "P. Giavedoni" 1 => "P. Iranzo" 2 => "I. Fuertes" 3 => "T. Estrach" 4 => "M. Alsina Gibert" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1016/j.ad.2014.12.003" "Revista" => array:6 [ "tituloSerie" => "Actas Dermosifiliogr" "fecha" => "2015" "volumen" => "106" "paginaInicial" => "310" "paginaFinal" => "316" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/25678133" "web" => "Medline" ] ] ] ] ] ] ] ] 4 => array:3 [ "identificador" => "bib0075" "etiqueta" => "5" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Systematic review of the adverse effects of cutaneous leishmaniasis treatment in the New World" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:6 [ 0 => "L.F. Oliveira" 1 => "A.O. Schubach" 2 => "M.M. Martins" 3 => "S.L. Passos" 4 => "R.V. Oliveira" 5 => "M.C. Marchi" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1016/j.actatropica.2011.02.007" "Revista" => array:6 [ "tituloSerie" => "Acta Trop" "fecha" => "2011" "volumen" => "118" "paginaInicial" => "87" "paginaFinal" => "96" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/21420925" "web" => "Medline" ] ] ] ] ] ] ] ] 5 => array:3 [ "identificador" => "bib0080" "etiqueta" => "6" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Electrocardiographic changes during low-dose, short-term therapy of cutaneous leishmaniasis with the pentavalent antimonial meglumine" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:5 [ 0 => "A.L. Ribeiro" 1 => "J.B. Drummond" 2 => "A.C. Volpini" 3 => "A.C. Andrade" 4 => "V.M. Passos" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1590/s0100-879x1999000300008" "Revista" => array:6 [ "tituloSerie" => "Braz J Med Biol Res" "fecha" => "1999" "volumen" => "32" "paginaInicial" => "297" "paginaFinal" => "301" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/10347787" "web" => "Medline" ] ] ] ] ] ] ] ] 6 => array:3 [ "identificador" => "bib0085" "etiqueta" => "7" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Intralesional meglumine antimoniate for the treatment of localised cutaneous leishmaniasis: a retrospective review of a Brazilian referral centre" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:5 [ 0 => "R.E. da Silva" 1 => "A. Toledo Júnior" 2 => "M.C. Senna" 3 => "A. Rabello" 4 => "G. Cota" ] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:5 [ "tituloSerie" => "Mem Inst Oswaldo Cruz" "fecha" => "2016" "volumen" => "111" "paginaInicial" => "512" "paginaFinal" => "516" ] ] ] ] ] ] 7 => array:3 [ "identificador" => "bib0090" "etiqueta" => "8" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Clinical features, epidemiology, and efficacy and safety of intralesional antimony treatment of cutaneous leishmaniasis: recent experience in Turkey" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:5 [ 0 => "S. Uzun" 1 => "M. Durdu" 2 => "G. Culha" 3 => "A.M. Allahverdiyev" 4 => "H.R. Memisoglu" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1645/GE-185R" "Revista" => array:6 [ "tituloSerie" => "J Parasitol" "fecha" => "2004" "volumen" => "90" "paginaInicial" => "853" "paginaFinal" => "859" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/15357081" "web" => "Medline" ] ] ] ] ] ] ] ] 8 => array:3 [ "identificador" => "bib0095" "etiqueta" => "9" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Adverse effects of intralesional meglumine antimoniate and its influence on clinical laboratory parameters in the treatment of cutaneous leishmaniasis: adverse effects of intralesional meglumine antimoniate in cutaneous leishmaniasis" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:5 [ 0 => "I. Esfandiarpour" 1 => "S. Farajzadeh" 2 => "Z. Rahnama" 3 => "E.A. Fathabadi" 4 => "A. Heshmatkhah" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1111/j.1365-4632.2012.05460.x" "Revista" => array:6 [ "tituloSerie" => "Int J Dermatol" "fecha" => "2012" "volumen" => "51" "paginaInicial" => "1221" "paginaFinal" => "1225" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/22994669" "web" => "Medline" ] ] ] ] ] ] ] ] 9 => array:3 [ "identificador" => "bib0100" "etiqueta" => "10" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Safety profile of meglumine antimoniate intralesional infiltration for cutaneous leishmaniasis" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:6 [ 0 => "H.J. Fernandes" 1 => "R.E. da Silva" 2 => "D.B. Ramalho" 3 => "M.G. Aguiar" 4 => "J.N. Silveira" 5 => "G. Cota" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1080/14787210.2020.1731305" "Revista" => array:6 [ "tituloSerie" => "Expert Rev Anti Infect Ther" "fecha" => "2020" "volumen" => "18" "paginaInicial" => "381" "paginaFinal" => "387" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/32067521" "web" => "Medline" ] ] ] ] ] ] ] ] ] ] ] ] ] "idiomaDefecto" => "en" "url" => "/00017310/0000011300000007/v1_202207140532/S0001731022005397/v1_202207140532/en/main.assets" "Apartado" => array:4 [ "identificador" => "6143" "tipo" => "SECCION" "en" => array:2 [ "titulo" => "Cartas científico-clínicas" "idiomaDefecto" => true ] "idiomaDefecto" => "en" ] "PDF" => "https://static.elsevier.es/multimedia/00017310/0000011300000007/v1_202207140532/S0001731022005397/v1_202207140532/en/main.pdf?idApp=UINPBA000044&text.app=https://actasdermo.org/" "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S0001731022005397?idApp=UINPBA000044"]

Estadísticas

Case and Research Letter

Electrocardiographic Alterations Related to Intralesional Glucantime® Treatments: A Potentially Severe Adverse Event

Alteraciones electrocardiográficas por Glucantime® intralesional, un evento adverso potencialmente grave

B. García Bracamonte

Autor para correspondencia

beagarcia50@hotmail.com

Corresponding author.

, S. Burillo Martínez, C. Morales Raya, P. Ortiz Romero

Hospital Universitario 12 de Octubre, Madrid, Spain

Leído

3954

Veces
se ha leído el artículo

1691

Total PDF

2263

Total HTML

Compartir estadísticas

 array:24 [
  "pii" => "S0001731022005397"
  "issn" => "00017310"
  "doi" => "10.1016/j.ad.2022.06.011"
  "estado" => "S300"
  "fechaPublicacion" => "2022-07-01"
  "aid" => "3095"
  "copyrightAnyo" => "2022"
  "documento" => "simple-article"
  "crossmark" => 1
  "licencia" => "http://creativecommons.org/licenses/by-nc-nd/4.0/"
  "subdocumento" => "crp"
  "cita" => "Actas Dermosifiliogr. 2022;113:T742-T744"
  "abierto" => array:3 [
    "ES" => true
    "ES2" => true
    "LATM" => true
  ]
  "gratuito" => true
  "lecturas" => array:1 [
    "total" => 0
  ]
  "itemSiguiente" => array:19 [
    "pii" => "S0001731022001612"
    "issn" => "00017310"
    "doi" => "10.1016/j.ad.2022.01.031"
    "estado" => "S300"
    "fechaPublicacion" => "2022-07-01"
    "aid" => "2950"
    "copyright" => "AEDV"
    "documento" => "simple-article"
    "crossmark" => 1
    "licencia" => "http://creativecommons.org/licenses/by-nc-nd/4.0/"
    "subdocumento" => "crp"
    "cita" => "Actas Dermosifiliogr. 2022;113:745-7"
    "abierto" => array:3 [
      "ES" => true
      "ES2" => true
      "LATM" => true
    ]
    "gratuito" => true
    "lecturas" => array:1 [
      "total" => 0
    ]
    "es" => array:11 [
      "idiomaDefecto" => true
      "cabecera" => "<span class="elsevierStyleTextfn">CARTA CIENT&#205;FICO-CL&#205;NICA</span>"
      "titulo" => "Seguimiento de pacientes con psoriasis en contexto de pol&#237;ticas de aislamiento domiciliario por COVID-19&#58; Encuesta realizada a pacientes en hospital de Argentina"
      "tienePdf" => "es"
      "tieneTextoCompleto" => "es"
      "paginas" => array:1 [
        0 => array:2 [
          "paginaInicial" => "745"
          "paginaFinal" => "747"
        ]
      ]
      "titulosAlternativos" => array:1 [
        "en" => array:1 [
          "titulo" => "Psoriasis While Home Isolation Policies to Contain COVID-19 Were in Effect&#58; A Follow-up Survey of Patients Treated at an Argentine Hospital"
        ]
      ]
      "contieneTextoCompleto" => array:1 [
        "es" => true
      ]
      "contienePdf" => array:1 [
        "es" => true
      ]
      "resumenGrafico" => array:2 [
        "original" => 0
        "multimedia" => array:7 [
          "identificador" => "fig0010"
          "etiqueta" => "Figura 2"
          "tipo" => "MULTIMEDIAFIGURA"
          "mostrarFloat" => true
          "mostrarDisplay" => false
          "figura" => array:1 [
            0 => array:4 [
              "imagen" => "gr2.jpeg"
              "Alto" => 768
              "Ancho" => 2091
              "Tamanyo" => 114426
            ]
          ]
          "descripcion" => array:1 [
            "es" => "<p id="spar0010" class="elsevierStyleSimplePara elsevierViewall">Causas de suspensi&#243;n de tratamiento durante el ASPO&#46;</p>"
          ]
        ]
      ]
      "autores" => array:1 [
        0 => array:2 [
          "autoresLista" => "Germ&#225;n Gast&#243;n Mangiarotti, Cintia Marisol Arias, Elizabeth Zak, Gimena Antonia Castro P&#233;rez"
          "autores" => array:4 [
            0 => array:2 [
              "nombre" => "Germ&#225;n Gast&#243;n"
              "apellidos" => "Mangiarotti"
            ]
            1 => array:2 [
              "nombre" => "Cintia Marisol"
              "apellidos" => "Arias"
            ]
            2 => array:2 [
              "nombre" => "Elizabeth"
              "apellidos" => "Zak"
            ]
            3 => array:2 [
              "nombre" => "Gimena Antonia"
              "apellidos" => "Castro P&#233;rez"
            ]
          ]
        ]
      ]
    ]
    "idiomaDefecto" => "es"
    "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S0001731022001612?idApp=UINPBA000044"
    "url" => "/00017310/0000011300000007/v1_202207140532/S0001731022001612/v1_202207140532/es/main.assets"
  ]
  "itemAnterior" => array:18 [
    "pii" => "S0001731022002551"
    "issn" => "00017310"
    "doi" => "10.1016/j.ad.2021.04.012"
    "estado" => "S300"
    "fechaPublicacion" => "2022-07-01"
    "aid" => "2986"
    "documento" => "simple-article"
    "crossmark" => 1
    "licencia" => "http://creativecommons.org/licenses/by-nc-nd/4.0/"
    "subdocumento" => "crp"
    "cita" => "Actas Dermosifiliogr. 2022;113:742-4"
    "abierto" => array:3 [
      "ES" => true
      "ES2" => true
      "LATM" => true
    ]
    "gratuito" => true
    "lecturas" => array:1 [
      "total" => 0
    ]
    "es" => array:11 [
      "idiomaDefecto" => true
      "cabecera" => "<span class="elsevierStyleTextfn">CARTA CIENT&#205;FICO-CL&#205;NICA</span>"
      "titulo" => "Alteraciones electrocardiogr&#225;ficas por Glucantime&#174; intralesional&#44; un evento adverso potencialmente grave"
      "tienePdf" => "es"
      "tieneTextoCompleto" => "es"
      "paginas" => array:1 [
        0 => array:2 [
          "paginaInicial" => "742"
          "paginaFinal" => "744"
        ]
      ]
      "titulosAlternativos" => array:1 [
        "en" => array:1 [
          "titulo" => "Electrocardiographic Alterations Related to Intralesional Glucantime&#174; Treatments&#58; A Potentially Severe Adverse Event"
        ]
      ]
      "contieneTextoCompleto" => array:1 [
        "es" => true
      ]
      "contienePdf" => array:1 [
        "es" => true
      ]
      "resumenGrafico" => array:2 [
        "original" => 0
        "multimedia" => array:7 [
          "identificador" => "fig0005"
          "etiqueta" => "Figura 1"
          "tipo" => "MULTIMEDIAFIGURA"
          "mostrarFloat" => true
          "mostrarDisplay" => false
          "figura" => array:1 [
            0 => array:4 [
              "imagen" => "gr1.jpeg"
              "Alto" => 468
              "Ancho" => 900
              "Tamanyo" => 66814
            ]
          ]
          "descripcion" => array:1 [
            "es" => "<p id="spar0005" class="elsevierStyleSimplePara elsevierViewall">Placa&#160;de 3&#44;5 cm&#44; eritematoedematosa e infiltrada localizada en la frente&#44;&#160;que correspond&#237;a a una lesi&#243;n por <span class="elsevierStyleItalic">Leishmania</span>&#46;</p>"
          ]
        ]
      ]
      "autores" => array:1 [
        0 => array:2 [
          "autoresLista" => "B&#46; Garc&#237;a Bracamonte, S&#46; Burillo Mart&#237;nez, C&#46; Morales Raya, P&#46; Ortiz Romero"
          "autores" => array:4 [
            0 => array:2 [
              "nombre" => "B&#46;"
              "apellidos" => "Garc&#237;a Bracamonte"
            ]
            1 => array:2 [
              "nombre" => "S&#46;"
              "apellidos" => "Burillo Mart&#237;nez"
            ]
            2 => array:2 [
              "nombre" => "C&#46;"
              "apellidos" => "Morales Raya"
            ]
            3 => array:2 [
              "nombre" => "P&#46;"
              "apellidos" => "Ortiz Romero"
            ]
          ]
        ]
      ]
    ]
    "idiomaDefecto" => "es"
    "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S0001731022002551?idApp=UINPBA000044"
    "url" => "/00017310/0000011300000007/v1_202207140532/S0001731022002551/v1_202207140532/es/main.assets"
  ]
  "asociados" => array:1 [
    0 => array:18 [
      "pii" => "S0001731022002551"
      "issn" => "00017310"
      "doi" => "10.1016/j.ad.2021.04.012"
      "estado" => "S300"
      "fechaPublicacion" => "2022-07-01"
      "aid" => "2986"
      "documento" => "simple-article"
      "crossmark" => 1
      "licencia" => "http://creativecommons.org/licenses/by-nc-nd/4.0/"
      "subdocumento" => "crp"
      "cita" => "Actas Dermosifiliogr. 2022;113:742-4"
      "abierto" => array:3 [
        "ES" => true
        "ES2" => true
        "LATM" => true
      ]
      "gratuito" => true
      "lecturas" => array:1 [
        "total" => 0
      ]
      "es" => array:11 [
        "idiomaDefecto" => true
        "cabecera" => "<span class="elsevierStyleTextfn">CARTA CIENT&#205;FICO-CL&#205;NICA</span>"
        "titulo" => "Alteraciones electrocardiogr&#225;ficas por Glucantime&#174; intralesional&#44; un evento adverso potencialmente grave"
        "tienePdf" => "es"
        "tieneTextoCompleto" => "es"
        "paginas" => array:1 [
          0 => array:2 [
            "paginaInicial" => "742"
            "paginaFinal" => "744"
          ]
        ]
        "titulosAlternativos" => array:1 [
          "en" => array:1 [
            "titulo" => "Electrocardiographic Alterations Related to Intralesional Glucantime&#174; Treatments&#58; A Potentially Severe Adverse Event"
          ]
        ]
        "contieneTextoCompleto" => array:1 [
          "es" => true
        ]
        "contienePdf" => array:1 [
          "es" => true
        ]
        "resumenGrafico" => array:2 [
          "original" => 0
          "multimedia" => array:7 [
            "identificador" => "fig0005"
            "etiqueta" => "Figura 1"
            "tipo" => "MULTIMEDIAFIGURA"
            "mostrarFloat" => true
            "mostrarDisplay" => false
            "figura" => array:1 [
              0 => array:4 [
                "imagen" => "gr1.jpeg"
                "Alto" => 468
                "Ancho" => 900
                "Tamanyo" => 66814
              ]
            ]
            "descripcion" => array:1 [
              "es" => "<p id="spar0005" class="elsevierStyleSimplePara elsevierViewall">Placa&#160;de 3&#44;5 cm&#44; eritematoedematosa e infiltrada localizada en la frente&#44;&#160;que correspond&#237;a a una lesi&#243;n por <span class="elsevierStyleItalic">Leishmania</span>&#46;</p>"
            ]
          ]
        ]
        "autores" => array:1 [
          0 => array:2 [
            "autoresLista" => "B&#46; Garc&#237;a Bracamonte, S&#46; Burillo Mart&#237;nez, C&#46; Morales Raya, P&#46; Ortiz Romero"
            "autores" => array:4 [
              0 => array:2 [
                "nombre" => "B&#46;"
                "apellidos" => "Garc&#237;a Bracamonte"
              ]
              1 => array:2 [
                "nombre" => "S&#46;"
                "apellidos" => "Burillo Mart&#237;nez"
              ]
              2 => array:2 [
                "nombre" => "C&#46;"
                "apellidos" => "Morales Raya"
              ]
              3 => array:2 [
                "nombre" => "P&#46;"
                "apellidos" => "Ortiz Romero"
              ]
            ]
          ]
        ]
      ]
      "idiomaDefecto" => "es"
      "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S0001731022002551?idApp=UINPBA000044"
      "url" => "/00017310/0000011300000007/v1_202207140532/S0001731022002551/v1_202207140532/es/main.assets"
    ]
  ]
  "en" => array:15 [
    "idiomaDefecto" => true
    "cabecera" => "<span class="elsevierStyleTextfn">Case and Research Letter</span>"
    "titulo" => " Electrocardiographic Alterations Related to Intralesional Glucantime&#174; Treatments&#58; A Potentially Severe Adverse Event"
    "tieneTextoCompleto" => true
    "saludo" => "To the Editor&#44;"
    "paginas" => array:1 [
      0 => array:2 [
        "paginaInicial" => "T742"
        "paginaFinal" => "T744"
      ]
    ]
    "autores" => array:1 [
      0 => array:4 [
        "autoresLista" => "B&#46; Garc&#237;a Bracamonte, S&#46; Burillo Mart&#237;nez, C&#46; Morales Raya, P&#46; Ortiz Romero"
        "autores" => array:4 [
          0 => array:4 [
            "nombre" => "B&#46;"
            "apellidos" => "Garc&#237;a Bracamonte"
            "email" => array:1 [
              0 => "beagarcia50@hotmail.com"
            ]
            "referencia" => array:1 [
              0 => array:2 [
                "etiqueta" => "<span class="elsevierStyleSup">&#42;</span>"
                "identificador" => "cor0005"
              ]
            ]
          ]
          1 => array:2 [
            "nombre" => "S&#46;"
            "apellidos" => "Burillo Mart&#237;nez"
          ]
          2 => array:2 [
            "nombre" => "C&#46;"
            "apellidos" => "Morales Raya"
          ]
          3 => array:2 [
            "nombre" => "P&#46;"
            "apellidos" => "Ortiz Romero"
          ]
        ]
        "afiliaciones" => array:1 [
          0 => array:2 [
            "entidad" => "Hospital Universitario 12 de Octubre&#44; Madrid&#44; Spain"
            "identificador" => "aff0005"
          ]
        ]
        "correspondencia" => array:1 [
          0 => array:3 [
            "identificador" => "cor0005"
            "etiqueta" => "&#8270;"
            "correspondencia" => "Corresponding author&#46;"
          ]
        ]
      ]
    ]
    "titulosAlternativos" => array:1 [
      "es" => array:1 [
        "titulo" => "Alteraciones electrocardiogr&#225;ficas por Glucantime&#174; intralesional&#44; un evento adverso potencialmente grave"
      ]
    ]
    "resumenGrafico" => array:2 [
      "original" => 0
      "multimedia" => array:7 [
        "identificador" => "fig0010"
        "etiqueta" => "Figure 2"
        "tipo" => "MULTIMEDIAFIGURA"
        "mostrarFloat" => true
        "mostrarDisplay" => false
        "figura" => array:1 [
          0 => array:4 [
            "imagen" => "gr2.jpeg"
            "Alto" => 1044
            "Ancho" => 1550
            "Tamanyo" => 439035
          ]
        ]
        "descripcion" => array:1 [
          "en" => "<p id="spar0010" class="elsevierStyleSimplePara elsevierViewall">Electrocardiogram &#40;ECG&#41; showing a prolonged QT interval &#40;QTc&#44; 510<span class="elsevierStyleHsp" style=""></span>ms&#41;&#44; nonsignificant ST segment depression&#44; and increased P wave axis&#46;</p>"
        ]
      ]
    ]
    "textoCompleto" => "<span class="elsevierStyleSections"><p id="par0005" class="elsevierStylePara elsevierViewall">Meglumine antimoniate &#40;MA&#41; &#40;Glucantime&#174;&#44; Sanofi-Aventis&#44; S&#46;A&#46;&#44; Spain&#41; is the treatment of choice in cutaneous leishmaniasis &#40;CL&#41;&#46;<a class="elsevierStyleCrossRefs" href="#bib0055"><span class="elsevierStyleSup">1&#8211;4</span></a> It is administered intramuscularly &#40;IM&#41; and intralesionally &#40;IL&#41;&#44; and is considered to be a safe and effective drug&#46; IL administration is used in single lesions smaller than 3&#8211;4<span class="elsevierStyleHsp" style=""></span>cm and IM administration is reserved for multiple lesions&#44; complicated lesions&#44; or cases with signs of lymphatic dissemination&#46;<a class="elsevierStyleCrossRefs" href="#bib0055"><span class="elsevierStyleSup">1&#44;3&#44;4</span></a> The recommended IM dosage is between 10 and 20<span class="elsevierStyleHsp" style=""></span>mg&#47;kg&#47;d of antimony &#40;75<span class="elsevierStyleHsp" style=""></span>mg&#47;kg&#47;d of MA&#41; in 10-day cycles&#46;<a class="elsevierStyleCrossRefs" href="#bib0065"><span class="elsevierStyleSup">3&#44;5&#8211;7</span></a> For IL administration&#44; much lower doses of between 0&#46;2 and 1<span class="elsevierStyleHsp" style=""></span>mL&#47;lesion are used&#44; in variable dosage regimens&#44; every 0&#46;5-1-2 weeks&#46;<a class="elsevierStyleCrossRefs" href="#bib0055"><span class="elsevierStyleSup">1&#44;3&#44;8</span></a> It is well known that systemic use of the drug may cause electrocardiographic abnormalities&#46;<a class="elsevierStyleCrossRef" href="#bib0065"><span class="elsevierStyleSup">3</span></a></p><p id="par0010" class="elsevierStylePara elsevierViewall">An 82-year-old woman visited our department with an erythematous&#8211;edematous infiltrated lesion measuring 3&#46;5<span class="elsevierStyleHsp" style=""></span>cm&#44; with no ulceration or scab&#44; located on the forehead&#59; the lesion was persistent and had appeared some months earlier &#40;<a class="elsevierStyleCrossRef" href="#fig0005">Fig&#46; 1</a>&#41;&#46; The patient had a past history of rheumatoid arthritis treated with etanercept and prednisone&#44; osteoporosis&#44; scoliosis&#44; mild anemia&#44; seborrheic dermatitis treated with topical corticosteroids&#44; and severe underweight &#40;BMI&#44; 15<span class="elsevierStyleHsp" style=""></span>kg&#47;m<span class="elsevierStyleSup">2</span>&#41;&#46; A skin biopsy of the lesion revealed granulomatous dermatitis with amastigotes and a diagnosis of leishmaniasis was therefore established&#46; The patient had not traveled outside Spain&#46; It was decided to treat the patient with oral itraconazole for 6 weeks&#44; with good clinical and analytical tolerance but without improvement&#46; A week later&#44; intralesional MA was administered at a dose of 0&#46;6&#8211;1<span class="elsevierStyleHsp" style=""></span>mL on days 0&#44; 7&#44; and 21&#44; following administration of lidocaine&#47;prilocaine&#46; The topical corticosteroids and etanercept were withdrawn from the moment of diagnosis&#46; An electrocardiogram &#40;ECG&#41; performed after the 3rd dose detected a prolonged QT interval &#40;QTc&#44; 510<span class="elsevierStyleHsp" style=""></span>ms&#41;&#44; nonsignificant ST segment depression&#44; and increased P wave axis &#40;<a class="elsevierStyleCrossRef" href="#fig0010">Fig&#46; 2</a>&#41;&#44; and treatment was therefore suspended&#46; The patient reported no episodes of syncope&#46; A follow-up ECG&#44; performed by the cardiology department 3 weeks later&#44; was within the normal range&#46; The cutaneous signs and symptoms resolved with the 3 doses that had already been administered&#46;</p><elsevierMultimedia ident="fig0005"></elsevierMultimedia><elsevierMultimedia ident="fig0010"></elsevierMultimedia><p id="par0015" class="elsevierStylePara elsevierViewall">Multiple adverse effects of systemic MA have been reported&#44; including myalgia&#44; arthralgia&#44; gastrointestinal disorders &#40;nausea&#44; abdominal pain&#41;&#44; headache&#44; elevated hepatic and pancreatic enzymes&#44; leukopenia&#44; abnormal ECG&#44; and severe arhythmia&#46;<a class="elsevierStyleCrossRefs" href="#bib0065"><span class="elsevierStyleSup">3&#44;5</span></a> Because it involves lower and more widely spaced doses&#44; intralesional use of MA produces mild and generally local adverse effects &#40;pain&#44; edema&#44; pruritus&#44; and transitory erythema at the injection site&#41;&#46;<a class="elsevierStyleCrossRefs" href="#bib0060"><span class="elsevierStyleSup">2&#44;4&#44;5&#44;7&#8211;10</span></a> Systemic adverse effects associated with this route of administration have also been described&#44; such as nausea&#44; vomiting&#44; dyspnea&#44; dizziness&#44; rash&#44; myalgia&#44; arthralgia&#44; headache&#44; and even anaphylactic shock&#46;<a class="elsevierStyleCrossRef" href="#bib0100"><span class="elsevierStyleSup">10</span></a> Cardiotoxicity due to systemic antimonials is a well-known adverse effect that&#44; according to the product information sheet&#44; may present when used at high daily doses over long periods of time&#46; It may produce a prolonged QT interval in the ECG&#44; with potential development of severe arrhythmia&#44; which may result in death&#46; Changes in the ECG are generally dose-dependent and are usually reversible&#46; In most cases&#44; abnormalities such as T wave inversion and prolonged QT interval precede onset and are a warning sign of potential severe arrhythmia&#46; A baseline ECG should be performed with a follow-up ECG every 7&#8211;10 days&#44; and treatment should be suspended if the QTc interval exceeds 450<span class="elsevierStyleHsp" style=""></span>ms&#46;<a class="elsevierStyleCrossRefs" href="#bib0075"><span class="elsevierStyleSup">5&#44;6&#44;9</span></a> Ribeiro et al&#46; also demonstrated changes in the ECG &#40;prolonged QT&#41; with systemic IM therapy at low doses &#40;10<span class="elsevierStyleHsp" style=""></span>mg&#47;kg&#41; and in short treatment durations &#40;10 days&#41; with potential severe implications&#44; which make monitoring these patients using ECG recommendable&#46;<a class="elsevierStyleCrossRef" href="#bib0080"><span class="elsevierStyleSup">6</span></a> With regard to intralesional therapy&#44; a recent clinical study in Brazil in 53 patients who underwent a weekly ECG found a prolonged QT interval with no clinical repercussions in 25&#37; of cases&#46;<a class="elsevierStyleCrossRef" href="#bib0100"><span class="elsevierStyleSup">10</span></a> This effect was found to be associated with smoking&#46;<a class="elsevierStyleCrossRef" href="#bib0100"><span class="elsevierStyleSup">10</span></a> It is&#44; however&#44; a poorly documented adverse effect&#44; as ECGs are not usually performed in the clinical follow-up of intralesional therapy&#46; In that study&#44; the weekly doses used were much higher than those in our study&#46; The fact that we detected this abnormality in a patient with no cardiologic risk criteria in treatment with low-dose intralesional MA leads us to believe that it is also useful to monitor the ECG in these patients&#46;</p><p id="par0020" class="elsevierStylePara elsevierViewall">In conclusion&#44; before instating therapy with antimonials in any form&#44; the patient should be questioned regarding personal history of cardiac disease &#40;heart attack&#44; bradycardia&#44; palpitations&#44; syncope&#44; etc&#46;&#41; and a family history of sudden death&#46; Factors that may favor prolonged QT&#44; such as electrolyte imbalance&#44; should be monitored and corrected and association with other drugs that may also cause prolonged QT &#40;<a href="http://www.qtdrugs.org/">www&#46;qtdrugs&#46;org</a>&#41; &#40;antiarrhythmics&#44; tricyclic antidepressants&#44; erythromycin&#44; tetracyclines&#44; trimethoprim&#47;sulfamethoxazole&#44; antipsychotics&#44; etc&#46;&#41; should be avoided&#46;<a class="elsevierStyleCrossRef" href="#bib0080"><span class="elsevierStyleSup">6</span></a> We recommend monitoring high-risk patients and watching for the appearance of a prolonged QT interval&#46;</p><span id="sec0005" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0005">Conflicts of Interest</span><p id="par0025" class="elsevierStylePara elsevierViewall">The authors declare that they have no conflicts of interest&#46;</p></span></span>"
    "textoCompletoSecciones" => array:1 [
      "secciones" => array:2 [
        0 => array:2 [
          "identificador" => "sec0005"
          "titulo" => "Conflicts of Interest"
        ]
        1 => array:1 [
          "titulo" => "References"
        ]
      ]
    ]
    "pdfFichero" => "main.pdf"
    "tienePdf" => true
    "multimedia" => array:2 [
      0 => array:7 [
        "identificador" => "fig0005"
        "etiqueta" => "Figure 1"
        "tipo" => "MULTIMEDIAFIGURA"
        "mostrarFloat" => true
        "mostrarDisplay" => false
        "figura" => array:1 [
          0 => array:4 [
            "imagen" => "gr1.jpeg"
            "Alto" => 469
            "Ancho" => 901
            "Tamanyo" => 67105
          ]
        ]
        "descripcion" => array:1 [
          "en" => "<p id="spar0005" class="elsevierStyleSimplePara elsevierViewall">Erythematous&#8211;edematous infiltrated plaque measuring 3&#46;5<span class="elsevierStyleHsp" style=""></span>cm&#44; located on the forehead&#44; corresponding to a lesion due to <span class="elsevierStyleItalic">Leishmania</span>&#46;</p>"
        ]
      ]
      1 => array:7 [
        "identificador" => "fig0010"
        "etiqueta" => "Figure 2"
        "tipo" => "MULTIMEDIAFIGURA"
        "mostrarFloat" => true
        "mostrarDisplay" => false
        "figura" => array:1 [
          0 => array:4 [
            "imagen" => "gr2.jpeg"
            "Alto" => 1044
            "Ancho" => 1550
            "Tamanyo" => 439035
          ]
        ]
        "descripcion" => array:1 [
          "en" => "<p id="spar0010" class="elsevierStyleSimplePara elsevierViewall">Electrocardiogram &#40;ECG&#41; showing a prolonged QT interval &#40;QTc&#44; 510<span class="elsevierStyleHsp" style=""></span>ms&#41;&#44; nonsignificant ST segment depression&#44; and increased P wave axis&#46;</p>"
        ]
      ]
    ]
    "bibliografia" => array:2 [
      "titulo" => "References"
      "seccion" => array:1 [
        0 => array:2 [
          "identificador" => "bibs0015"
          "bibliografiaReferencia" => array:10 [
            0 => array:3 [
              "identificador" => "bib0055"
              "etiqueta" => "1"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Outbreak of cutaneous leishmaniasis in Fuenlabrada&#44; Madrid"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => false
                          "autores" => array:6 [
                            0 => "M&#46; Aguado"
                            1 => "P&#46; Espinosa"
                            2 => "A&#46; Romero-Mat&#233;"
                            3 => "J&#46;C&#46; Tard&#237;o"
                            4 => "S&#46; C&#243;rdoba"
                            5 => "J&#46; Borbujo"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:2 [
                      "doi" => "10.1016/j.adengl.2013.03.005"
                      "Revista" => array:6 [
                        "tituloSerie" => "Actas Dermosifiliogr"
                        "fecha" => "2013"
                        "volumen" => "104"
                        "paginaInicial" => "334"
                        "paginaFinal" => "342"
                        "link" => array:1 [
                          0 => array:2 [
                            "url" => "https://www.ncbi.nlm.nih.gov/pubmed/23567452"
                            "web" => "Medline"
                          ]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            1 => array:3 [
              "identificador" => "bib0060"
              "etiqueta" => "2"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Efficacy of pentavalent antimoniate intralesional infiltration therapy for cutaneous leishmaniasis&#58; a systematic review"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => false
                          "autores" => array:3 [
                            0 => "N&#46;C&#46; Brito"
                            1 => "A&#46; Rabello"
                            2 => "G&#46;F&#46; Cota"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:2 [
                      "doi" => "10.1371/journal.pone.0184777"
                      "Revista" => array:6 [
                        "tituloSerie" => "PLOS ONE"
                        "fecha" => "2017"
                        "volumen" => "12"
                        "paginaInicial" => "e0184777"
                        "link" => array:1 [
                          0 => array:2 [
                            "url" => "https://www.ncbi.nlm.nih.gov/pubmed/28926630"
                            "web" => "Medline"
                          ]
                        ]
                        "itemHostRev" => array:3 [
                          "pii" => "S1550728914004055"
                          "estado" => "S300"
                          "issn" => "15507289"
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            2 => array:3 [
              "identificador" => "bib0065"
              "etiqueta" => "3"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Leishmaniasis cut&#225;nea"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => false
                          "autores" => array:1 [
                            0 => "D&#46; Garc&#237;a-Almagro"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:2 [
                      "doi" => "10.1016/s0001-7310(05)73027-1"
                      "Revista" => array:6 [
                        "tituloSerie" => "Actas Dermosifiliogr"
                        "fecha" => "2005"
                        "volumen" => "96"
                        "paginaInicial" => "1"
                        "paginaFinal" => "24"
                        "link" => array:1 [
                          0 => array:2 [
                            "url" => "https://www.ncbi.nlm.nih.gov/pubmed/16476327"
                            "web" => "Medline"
                          ]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            3 => array:3 [
              "identificador" => "bib0070"
              "etiqueta" => "4"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Cutaneous leishmaniasis&#58; 20 years&#8217; experience in a Spanish tertiary care hospital"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => false
                          "autores" => array:5 [
                            0 => "P&#46; Giavedoni"
                            1 => "P&#46; Iranzo"
                            2 => "I&#46; Fuertes"
                            3 => "T&#46; Estrach"
                            4 => "M&#46; Alsina Gibert"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:2 [
                      "doi" => "10.1016/j.ad.2014.12.003"
                      "Revista" => array:6 [
                        "tituloSerie" => "Actas Dermosifiliogr"
                        "fecha" => "2015"
                        "volumen" => "106"
                        "paginaInicial" => "310"
                        "paginaFinal" => "316"
                        "link" => array:1 [
                          0 => array:2 [
                            "url" => "https://www.ncbi.nlm.nih.gov/pubmed/25678133"
                            "web" => "Medline"
                          ]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            4 => array:3 [
              "identificador" => "bib0075"
              "etiqueta" => "5"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Systematic review of the adverse effects of cutaneous leishmaniasis treatment in the New World"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => true
                          "autores" => array:6 [
                            0 => "L&#46;F&#46; Oliveira"
                            1 => "A&#46;O&#46; Schubach"
                            2 => "M&#46;M&#46; Martins"
                            3 => "S&#46;L&#46; Passos"
                            4 => "R&#46;V&#46; Oliveira"
                            5 => "M&#46;C&#46; Marchi"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:2 [
                      "doi" => "10.1016/j.actatropica.2011.02.007"
                      "Revista" => array:6 [
                        "tituloSerie" => "Acta Trop"
                        "fecha" => "2011"
                        "volumen" => "118"
                        "paginaInicial" => "87"
                        "paginaFinal" => "96"
                        "link" => array:1 [
                          0 => array:2 [
                            "url" => "https://www.ncbi.nlm.nih.gov/pubmed/21420925"
                            "web" => "Medline"
                          ]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            5 => array:3 [
              "identificador" => "bib0080"
              "etiqueta" => "6"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Electrocardiographic changes during low-dose&#44; short-term therapy of cutaneous leishmaniasis with the pentavalent antimonial meglumine"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => false
                          "autores" => array:5 [
                            0 => "A&#46;L&#46; Ribeiro"
                            1 => "J&#46;B&#46; Drummond"
                            2 => "A&#46;C&#46; Volpini"
                            3 => "A&#46;C&#46; Andrade"
                            4 => "V&#46;M&#46; Passos"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:2 [
                      "doi" => "10.1590/s0100-879x1999000300008"
                      "Revista" => array:6 [
                        "tituloSerie" => "Braz J Med Biol Res"
                        "fecha" => "1999"
                        "volumen" => "32"
                        "paginaInicial" => "297"
                        "paginaFinal" => "301"
                        "link" => array:1 [
                          0 => array:2 [
                            "url" => "https://www.ncbi.nlm.nih.gov/pubmed/10347787"
                            "web" => "Medline"
                          ]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            6 => array:3 [
              "identificador" => "bib0085"
              "etiqueta" => "7"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Intralesional meglumine antimoniate for the treatment of localised cutaneous leishmaniasis&#58; a retrospective review of a Brazilian referral centre"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => false
                          "autores" => array:5 [
                            0 => "R&#46;E&#46; da Silva"
                            1 => "A&#46; Toledo J&#250;nior"
                            2 => "M&#46;C&#46; Senna"
                            3 => "A&#46; Rabello"
                            4 => "G&#46; Cota"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:1 [
                      "Revista" => array:5 [
                        "tituloSerie" => "Mem Inst Oswaldo Cruz"
                        "fecha" => "2016"
                        "volumen" => "111"
                        "paginaInicial" => "512"
                        "paginaFinal" => "516"
                      ]
                    ]
                  ]
                ]
              ]
            ]
            7 => array:3 [
              "identificador" => "bib0090"
              "etiqueta" => "8"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Clinical features&#44; epidemiology&#44; and efficacy and safety of intralesional antimony treatment of cutaneous leishmaniasis&#58; recent experience in Turkey"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => false
                          "autores" => array:5 [
                            0 => "S&#46; Uzun"
                            1 => "M&#46; Durdu"
                            2 => "G&#46; Culha"
                            3 => "A&#46;M&#46; Allahverdiyev"
                            4 => "H&#46;R&#46; Memisoglu"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:2 [
                      "doi" => "10.1645/GE-185R"
                      "Revista" => array:6 [
                        "tituloSerie" => "J Parasitol"
                        "fecha" => "2004"
                        "volumen" => "90"
                        "paginaInicial" => "853"
                        "paginaFinal" => "859"
                        "link" => array:1 [
                          0 => array:2 [
                            "url" => "https://www.ncbi.nlm.nih.gov/pubmed/15357081"
                            "web" => "Medline"
                          ]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            8 => array:3 [
              "identificador" => "bib0095"
              "etiqueta" => "9"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Adverse effects of intralesional meglumine antimoniate and its influence on clinical laboratory parameters in the treatment of cutaneous leishmaniasis&#58; adverse effects of intralesional meglumine antimoniate in cutaneous leishmaniasis"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => false
                          "autores" => array:5 [
                            0 => "I&#46; Esfandiarpour"
                            1 => "S&#46; Farajzadeh"
                            2 => "Z&#46; Rahnama"
                            3 => "E&#46;A&#46; Fathabadi"
                            4 => "A&#46; Heshmatkhah"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:2 [
                      "doi" => "10.1111/j.1365-4632.2012.05460.x"
                      "Revista" => array:6 [
                        "tituloSerie" => "Int J Dermatol"
                        "fecha" => "2012"
                        "volumen" => "51"
                        "paginaInicial" => "1221"
                        "paginaFinal" => "1225"
                        "link" => array:1 [
                          0 => array:2 [
                            "url" => "https://www.ncbi.nlm.nih.gov/pubmed/22994669"
                            "web" => "Medline"
                          ]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            9 => array:3 [
              "identificador" => "bib0100"
              "etiqueta" => "10"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Safety profile of meglumine antimoniate intralesional infiltration for cutaneous leishmaniasis"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => false
                          "autores" => array:6 [
                            0 => "H&#46;J&#46; Fernandes"
                            1 => "R&#46;E&#46; da Silva"
                            2 => "D&#46;B&#46; Ramalho"
                            3 => "M&#46;G&#46; Aguiar"
                            4 => "J&#46;N&#46; Silveira"
                            5 => "G&#46; Cota"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:2 [
                      "doi" => "10.1080/14787210.2020.1731305"
                      "Revista" => array:6 [
                        "tituloSerie" => "Expert Rev Anti Infect Ther"
                        "fecha" => "2020"
                        "volumen" => "18"
                        "paginaInicial" => "381"
                        "paginaFinal" => "387"
                        "link" => array:1 [
                          0 => array:2 [
                            "url" => "https://www.ncbi.nlm.nih.gov/pubmed/32067521"
                            "web" => "Medline"
                          ]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
          ]
        ]
      ]
    ]
  ]
  "idiomaDefecto" => "en"
  "url" => "/00017310/0000011300000007/v1_202207140532/S0001731022005397/v1_202207140532/en/main.assets"
  "Apartado" => array:4 [
    "identificador" => "6143"
    "tipo" => "SECCION"
    "en" => array:2 [
      "titulo" => "Cartas cient&#237;fico-cl&#237;nicas"
      "idiomaDefecto" => true
    ]
    "idiomaDefecto" => "en"
  ]
  "PDF" => "https://static.elsevier.es/multimedia/00017310/0000011300000007/v1_202207140532/S0001731022005397/v1_202207140532/en/main.pdf?idApp=UINPBA000044&text.app=https://actasdermo.org/"
  "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S0001731022005397?idApp=UINPBA000044"
]

Información del artículo

ISSN: 00017310
Idioma original: Inglés

DOI:10.1016/j.ad.2022.06.011

Datos actualizados diariamente

año/Mes	Html	Pdf	Total

2024 Noviembre	13	15	28
2024 Octubre	142	76	218
2024 Septiembre	130	61	191
2024 Agosto	147	91	238
2024 Julio	89	74	163
2024 Junio	110	73	183
2024 Mayo	88	62	150
2024 Abril	80	64	144
2024 Marzo	79	89	168
2024 Febrero	63	74	137
2024 Enero	61	60	121
2023 Diciembre	58	41	99
2023 Noviembre	66	62	128
2023 Octubre	56	39	95
2023 Septiembre	57	31	88
2023 Agosto	59	22	81
2023 Julio	72	46	118
2023 Junio	54	28	82
2023 Mayo	63	24	87
2023 Abril	47	23	70
2023 Marzo	49	35	84
2023 Febrero	53	42	95
2023 Enero	49	63	112
2022 Diciembre	63	55	118
2022 Noviembre	56	69	125
2022 Octubre	70	59	129
2022 Septiembre	62	91	153
2022 Agosto	99	71	170
2022 Julio	158	75	233
2022 Junio	70	76	146

Mostrar todo

Indexada en:

Síguenos:

Estadísticas

Indexada en:

Síguenos:

Estadísticas

Suscríbase a la newsletter